Dina Halegoua-DeMarzio

Thomas Jefferson University

Appearances

Therapeutic Choice and the Pipeline for MASLD and MASH
Date
May 19, 2024
SOCIETY: AASLD
Moderators
Meagan Gray
University of Alabama at Birmingham School of Medicine
Dina Halegoua-DeMarzio
Thomas Jefferson University
FEMALES WITH AUTOIMMUNE LIVER DISEASES ARE AT INCREASED RISK OF MAJOR ADVERSE CARDIOVASCULAR OUTCOMES: A NATIONWIDE MATCHED COHORT STUDY
Date
May 21, 2024
Cardiovascular disease (CVD) remains a leading cause of death in women. The Atherosclerotic Cardiovascular Disease 10-year risk score recommended by the American College of Cardiology does not encompass chronic inflammatory diseases, which is associated with increased CVD risk…
Presenter
Rachel Redfield
Speakers
Joy Zhao
Tammy Tran
Dina Halegoua-DeMarzio
Thomas Jefferson University